Notably, the panel refuted RYR2 as an ARVC gene, finding P/LP variants in RYR2 typically cause catecholaminergic polymorphic ventricular tachycardia (CPVT) not ARVC. This evidence concerns the gene RYR2 and Arrhythmogenic right ventricular dysplasia.